These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 27355898)

  • 61. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.
    Jackman RJ; Burbank F; Parker SH; Evans WP; Lechner MC; Richardson TR; Smid AA; Borofsky HB; Lee CH; Goldstein HM; Schilling KJ; Wray AB; Brem RF; Helbich TH; Lehrer DE; Adler SJ
    Radiology; 2001 Feb; 218(2):497-502. PubMed ID: 11161168
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy.
    Jackman RJ; Burbank F; Parker SH; Evans WP; Lechner MC; Richardson TR; Tocino I; Wray AB
    Radiology; 1997 Aug; 204(2):485-8. PubMed ID: 9240540
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vacuum assisted breast biopsy (VAB) excision of subcentimeter microcalcifications as an alternative to open biopsy for atypical ductal hyperplasia.
    Schiaffino S; Massone E; Gristina L; Fregatti P; Rescinito G; Villa A; Friedman D; Calabrese M
    Br J Radiol; 2018 May; 91(1085):20180003. PubMed ID: 29451396
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Can US-guided vacuum-assisted biopsies be an alternative to diagnostic surgery in cases of non-diagnostic core needle biopsy?].
    Carpentier E; Maruani A; Michenet P; Bonneau C; Degand P; Lebas P
    J Radiol; 2005 May; 86(5 Pt 1):475-80. PubMed ID: 16114203
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
    Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
    Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates.
    Houssami N; Ciatto S; Ellis I; Ambrogetti D
    Cancer; 2007 Feb; 109(3):487-95. PubMed ID: 17186530
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy.
    Cha E; Ambinder EB; Oluyemi ET; Mullen LA; Panigrahi B; Rossi J; Di Carlo PA; Myers KS
    Breast Cancer Res Treat; 2022 Dec; 196(3):517-525. PubMed ID: 36242709
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Deep-learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy.
    Huang CY; Chang RF; Lin CY; Hsieh MS; Liao PC; Wang YJ; Kao YC; Porta L; Lin PY; Lee CC; Lee YH
    Histopathology; 2024 May; 84(6):983-1002. PubMed ID: 38288642
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
    Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
    Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Atypical ductal hyperplasia at margin of breast biopsy--is re-excision indicated?
    Arora S; Menes TS; Moung C; Nagi C; Bleiweiss I; Jaffer S
    Ann Surg Oncol; 2008 Mar; 15(3):843-7. PubMed ID: 17987337
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy.
    Moore MM; Hargett CW; Hanks JB; Fajardo LL; Harvey JA; Frierson HF; Slingluff CL
    Ann Surg; 1997 Jun; 225(6):726-31; discussion 731-3. PubMed ID: 9230813
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative features of carcinoma in situ and atypical ductal hyperplasia of the breast on fine-needle aspiration biopsy specimens.
    Abendroth CS; Wang HH; Ducatman BS
    Am J Clin Pathol; 1991 Nov; 96(5):654-9. PubMed ID: 1659182
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stereotactic 9-gauge vacuum-assisted breast biopsy, how many specimens are needed?
    den Dekker BM; van Diest PJ; de Waard SN; Verkooijen HM; Pijnappel RM
    Eur J Radiol; 2019 Nov; 120():108665. PubMed ID: 31563108
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Upgrade Rate of Percutaneously Diagnosed Pure Atypical Ductal Hyperplasia: Systematic Review and Meta-Analysis of 6458 Lesions.
    Schiaffino S; Calabrese M; Melani EF; Trimboli RM; Cozzi A; Carbonaro LA; Di Leo G; Sardanelli F
    Radiology; 2020 Jan; 294(1):76-86. PubMed ID: 31660803
    [TBL] [Abstract][Full Text] [Related]  

  • 75. US-guided 14G core needle biopsy: comparison between underestimated and correctly diagnosed breast cancers.
    Kim H; Youk JH; Kim JA; Gweon HM; Jung WH; Son EJ
    Asian Pac J Cancer Prev; 2014; 15(7):3179-83. PubMed ID: 24815467
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of percutaneous vacuum assisted intact specimen breast biopsy device for ultrasound visualized breast lesions: Upstage rates and long term follow-up for high risk lesions and DCIS.
    Graham CL
    Breast; 2017 Jun; 33():38-43. PubMed ID: 28279887
    [TBL] [Abstract][Full Text] [Related]  

  • 77. BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ.
    Tozaki M
    Breast Cancer; 2013 Jan; 20(1):13-20. PubMed ID: 22109641
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy.
    Winchester DJ; Bernstein JR; Jeske JM; Nicholson MH; Hahn EA; Goldschmidt RA; Watkin WG; Sener SF; Bilimoria MB; Barrera E; Winchester DP
    Arch Surg; 2003 Jun; 138(6):619-22; discussion 622-3. PubMed ID: 12799332
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.
    Allen SD; Osin P; Nerurkar A
    Eur J Surg Oncol; 2014 Jul; 40(7):824-9. PubMed ID: 24742589
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
    Wagoner MJ; Laronga C; Acs G
    Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.